1171 - 1180 of 8142 Results
Title
Year
-
RESTRICTEDTitle: Methods and applications for single-cell and spatial multi-omicsJournal Name: Nature Reviews GeneticsPublisher: Springer Science and Business Media LLCVol: 24Issue #: 8Start Page: 494End Page: 515Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41576-023-00580-2Best OA location URL: https://www.nature.com/articles/s41576-023-00580-2.pdfCitation Count: 185
- Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment2023OPENTitle: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1069411Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1069411/pdfCitation Count: 17
- Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease2023OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 6
- Dementia prevention in memory clinics: recommendations from the European task force for brain health services2023RESTRICTEDTitle: Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesJournal Name: The Lancet Regional Health - EuropePublisher: Elsevier BVVol: 26Issue #:Start Page: 100576End Page: 100576Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100576Best OA location URL: https://doi.org/10.1016/j.lanepe.2022.100576Citation Count: 41
- Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease2023OPENTitle: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 3Start Page: 112231End Page: 112231Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231Best OA location URL: http://www.cell.com/article/S2211124723002425/pdfCitation Count: 31
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
- Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s Disease2023OPENTitle: Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s DiseaseJournal Name: Molecular ImagingPublisher: SAGE PublicationsVol: 2023Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/1855985Best OA location URL: https://downloads.hindawi.com/journals/moi/2023/1855985.pdfCitation Count: 10
- LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts2023OPENTitle: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00468-2Best OA location URL: https://www.nature.com/articles/s41531-023-00468-2.pdfCitation Count: 14
-
OPENTitle: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 885End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29358Citation Count: 27
- Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's Disease2023RESTRICTEDTitle: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's DiseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5281/zenodo.7679354Citation Count: 1